Exercise Intervention for Cancer Survivors and Caregivers
NCT ID: NCT01883635
Last Updated: 2016-02-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
44 participants
INTERVENTIONAL
2013-05-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors
NCT00246818
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
NCT05763563
Effects of Yoga, Strength Training and Aerobic Exercise on Cognition in Adult Cancer Survivors
NCT03650322
Lung Cancer Exercise Training Study
NCT01068210
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
NCT03284346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individual Exercise Intervention
Survivor-only progressive walking and resistance exercise
Survivor-only progressive walking and resistance exercise
Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor only
Dyadic Exercise Intervention
Dyadic progressive walking and resistance exercise
Dyadic progressive walking and resistance exercise
Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor and caregiver as a dyad
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survivor-only progressive walking and resistance exercise
Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor only
Dyadic progressive walking and resistance exercise
Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor and caregiver as a dyad
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a functional capacity rating of 70 or greater on the Karnofsky Performance Scale or a rating of 1 or 0 on the ECOG scale when assessed by a medical oncologist (or physicians designee) following cancer treatments
* Have a caregiver willing to participate int he study
* Be able to read English
* Be 21 years of age or older
* Give written informed consent
* Be nominated by a cancer survivor
* Be able to read English
* Be 21 years of age or older
* Give written informed consent
Exclusion Criteria
* For caregivers, be currently undergoing active treatment for cancer
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charles Kamen
Assistant Research Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Kamen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
46413
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.